• 1. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 4. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 5. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Glycosyl compounds

Benzoic acid,4-methoxy-2-[(6-O-b-D-xylopyranosyl-b-D-glucopyranosyl)oxy]-, methyl ester: A Comprehensive Overview

Benzoic acid,4-methoxy-2-[(6-O-b-D-xylopyranosyl-b-D-glucopyranosyl)oxy]-, methyl ester, with the CAS number 154-60-9, is a complex glycoside derivative of benzoic acid that has garnered significant attention in the field of pharmaceutical chemistry and biochemistry. This compound represents a fascinating intersection of organic synthesis and natural product chemistry, featuring a highly functionalized aromatic core linked to a polysaccharide-like moiety. The presence of multiple glycosidic bonds and a methoxy group on the benzene ring endows it with unique chemical and biological properties that make it a subject of intense research interest.

The structure of Benzoic acid,4-methoxy-2-[(6-O-b-D-xylopyranosyl-b-D-glucopyranosyl)oxy]-, methyl ester is characterized by its intricate glycosylation pattern. The benzene ring is substituted at the 4-position with a methoxy group and at the 2-position with a disaccharide chain composed of b-D-glucopyranosyl and b-D-xylopyranosyl units. This disaccharide moiety is linked to the benzene ring via an ether oxygen atom, forming a glycosidic bond. The overall molecular architecture suggests potential biological activities associated with both the benzoic acid scaffold and the polysaccharide-like segment.

In recent years, there has been growing interest in glycosylated benzoic acid derivatives due to their reported pharmacological properties. The combination of the benzoic acid moiety, known for its antimicrobial and anti-inflammatory effects, with the polysaccharide segment, which often exhibits immunomodulatory and anti-tumor activities, makes this compound a promising candidate for drug development. Specifically, the disaccharide chain has been shown to enhance solubility and bioavailability, which are critical factors in pharmaceutical formulations.

Recent studies have explored the synthetic pathways for obtaining Benzoic acid,4-methoxy-2-[(6-O-b-D-xylopyranosyl-b-D-glucopyranosyl)oxy]-, methyl ester. One approach involves the glycosylation of 4-methoxybenzoic acid with protected sugars followed by deprotection steps. Alternatively, enzymatic methods using glycosidases have been investigated for their potential to produce more complex glycosides with higher regioselectivity and lower environmental impact. These synthetic strategies are crucial for ensuring the availability of this compound for further research and development.

The biological activity of Benzoic acid,4-methoxy-2-[(6-O-b-D-xylopyranosyl-b-D-glucopyranosyl)oxy]-, methyl ester has been extensively studied in various in vitro and in vivo models. Preliminary findings suggest that this compound may exhibit anti-cancer properties by inhibiting key enzymes involved in tumor proliferation and metastasis. Additionally, its potential role in modulating immune responses has been explored, particularly in contexts where immune dysregulation is a concern. These findings are supported by structural analog studies that highlight the importance of the glycosidic linkage in determining biological activity.

The pharmacokinetic profile of this compound is another area of active investigation. The presence of multiple hydroxyl groups and glycosidic bonds suggests that it may exhibit prolonged circulation time due to interactions with plasma proteins. Furthermore, its solubility characteristics could be enhanced by the polysaccharide segment, potentially leading to improved oral bioavailability. Understanding these pharmacokinetic parameters is essential for optimizing therapeutic dosing and formulation design.

In conclusion, Benzoic acid,4-methoxy-2-[(6-O-b-D-xylopyranosyl-b-D-glucopyranosyl)oxy]-, methyl ester represents a structurally complex yet biologically promising compound that warrants further exploration in pharmaceutical research. Its unique combination of chemical features positions it as a valuable tool for developing novel therapeutic agents targeting various diseases. As synthetic methodologies continue to advance and our understanding of its biological effects deepens, this compound is poised to make significant contributions to medicine.

• 71953-77-0(b-D-Glucopyranoside, 2-[[[3-(b-D-glucopyranosyloxy)-6-hydroxy-2-methoxybenzoyl]oxy]methyl]phenyl)
• 99-17-2(Populin)
• 108124-75-0(6-(beta-D-glucopyranosyloxy)-salicylic acid methyl ester)
• 72021-23-9(Henryoside)
• 85643-19-2(Curculigoside)
• 154-61-0(Benzoic acid,5-methoxy-2-[(6-O-b-D-xylopyranosyl-b-D-glucopyranosyl)oxy]-, methyl ester)
• 18463-25-7(Nigracin)
• 490-67-5(Gaultherin)
• 143601-09-6(Curculigoside B)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)